Nephrogenic Systemic Fibrosis Risk and Liver Disease

Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis, hepatocellular carcinoma (HCC), or both from...

Full description

Bibliographic Details
Main Authors: Robert F. Hanna, Lee A. Finkelstone, Daniel S. Chow, Vesselin Z. Miloushev, Mark R. Escudero, Stephen M. Lagana, Martin R. Prince
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2014/679605